From market question to market execution.

AI-native market entry platform for pharma, biotech, and medtech teams, across 90 markets including all 50 US states.

MARKET BRIEF 🇻🇳
COMPARE 🇧🇷🇨🇴🇲🇽
TOP 5 🌏
GVD 🇮🇩
PRICING 🇨🇱
REG TRACKER 🇵🇭
MARKET BRIEF
MARKET BRIEF
Vietnam · GLP-1 Receptor Agonist
DECISIONEnter with conditions: BHYT formulary listing required; 18-24 month access timeline.
Two doors, one platform

Which are you bringing to market?

The data underneath is the same across 90 markets. What leads, and how the decision is framed, differs by track.

Medtech track

Medtech and diagnostics

Conformity routes, reference agency reliance, procurement and local representation, read for a device.

  • IVDs and diagnostics
  • Medical devices, Class I to III
  • Software as a medical device
  • Digital health and connected devices
  • Imaging and capital equipment
Explore the medtech track →
Pharma track

Pharma and biotech

Approval, HTA, reference pricing and formulary access, read for a therapeutic.

  • Small molecules and drugs
  • Biologics and biosimilars
  • Specialty and rare disease
  • Vaccines
  • Biotech therapeutics
Explore the pharma track →
90
Markets covered
Cited
To primary sources
$20-40K
Typical consultant quote
The framework

Six dimensions, rated the same way in every market

Each one rated Ready, Moderate, or Complex, calibrated to your product type and the clearances you already hold. No composite score, no weighted average.

01

Regulatory pathway

The approval or conformity route your existing clearances open, whether the authority runs a reliance route, and which agencies it treats as reference.

02

Timeline

The published clock for the route you qualify for, in the regulator’s own units, or marked as unpublished.

03

Procurement structure

Who actually buys, tender, formulary, hospital group or distributor tier, and what registration or listing status is required.

04

Pricing environment

How price is set and constrained, and the effect of a first accepted price on the markets that price against it.

05

Local partner requirements

The representative, agent, sponsor or licensed establishment the market requires, and whether it must exist before the clock starts.

06

Tax and customs

Import duty, customs treatment, and the free-zone question.

The full workflow, one product
One decision. Eight ways in.
A medical device entering Indonesia. Each tool answers one question, and hands the next its answer.
01 · Map, learn the market
02 · Decide, weigh the move
03 · Execute, make it happen
MARKET BRIEF✓ cited to source
Asks: can we legally sell here at all?
Yes, but no shortcut. Approval takes 6 to 9 months and a local partner must own the licence.
Your US and EU clearances help but do not fast-track you. Indonesia's regulator (BPOM) runs a full review, and only a licensed local distributor can hold the registration.
US/EU clearanceHelps, not enough
Approval time6 to 9 months
Who holds licenceLocal distributor
If it takes that long, is Indonesia even worth doing first? Rank it against everywhere else.
↓ EIGHT ANSWERS, ONE DECISION
Enter the Philippines first. Run Indonesia in parallel, sell through private hospitals, and plan for 10 to 15 months. Watch the local-content rule closely.
Every step above is real Vantro output. Run it for your market.

Contact us.

Whether you have a specific market question, want to book a call, or are interested in a subscription, drop us a message.

Or
Book a call →

30 minutes. We'll walk you through the platform and answer any questions about your specific markets and product type.